Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.48 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18799364 | 0.91 | ACHE (0.54) | ACHEPOLBSIGMAR1 | |
| SCHEMBL2608042 | 0.91 | ACHE (0.54) | ACHEPOLBSIGMAR1 | |
| SCHEMBL11494532 | 0.82 | NPC1 (0.52) | NPC1RAB9A | |
| SCHEMBL4244929 | 0.82 | TSHR (0.48) | ACHE | |
| SCHEMBL3344245 | 0.82 | ACHE (0.61) | CD274ACHE | |
| SCHEMBL17073861 | 0.80 | NPC1 (0.50) | NPC1RAB9AHPGDCD274 | |
| SCHEMBL18383795 | 0.80 | NPC1 (0.50) | NPC1RAB9AHPGDCD274 | |
| SCHEMBL11485679 | 0.77 | ALDH1A1 (0.51) | NPC1RAB9APOLBSIGMAR1 | |
| SCHEMBL28316666 | 0.76 | ALDH1A1 (0.54) | RAB9ASIGMAR1 | |
| SCHEMBL9796769 | 0.76 | ALDH1A1 (0.54) | RAB9ASIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2049118-A1 | MORPHOLINYL AND PYRROLIDINYL ANALOGS | SmithKline Beecham Corporation (US) | 2009-04-22 | — | — | EP | disclosed |
| WO-2008011551-A1 | MORPHOLINYL AND PYRROLIDINYL ANALOGS | SMITHKLINE BEECHAM CORPORATION (US) | 2008-01-24 | — | — | WO | disclosed |